Viral kinetics are associated with changes in cytokines and chemokines in serum and target organs of SSM-CVB3-infected macaques

Abzug, 2001, Prognosis for neonates with enterovirus hepatitis and coagulopathy, The Pediatric Infectious Disease Journal, 20, 758, 10.1097/00006454-200108000-00008 Akira, 2001, Toll-like receptors: critical proteins linking innate and acquired immunity, Nature Immunology, 2, 675, 10.1038/90609 Arai, 1990, Cytokines: coordinators of immune and inflammatory responses, Annual Review of Biochemistry, 59, 783, 10.1146/annurev.bi.59.070190.004031 Cohen, 1996, Cytokine function: a study in biologic diversity, American Journal of Clinical Pathology, 105, 589, 10.1093/ajcp/105.5.589 Curfs, 1997, A primer on cytokines: sources, receptors, effects, and inducers, Clinical Microbiology Reviews, 10, 742, 10.1128/CMR.10.4.742 Fairweather, 2004, Women and autoimmune diseases, Emerging Infectious Diseases, 10, 2005, 10.3201/eid1011.040367 Fairweather, 2001, From infection to autoimmunity, Journal of Autoimmunity, 16, 175, 10.1006/jaut.2000.0492 Fairweather, 2004, Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection, Autoimmunity, 37, 131, 10.1080/0891693042000196200 Frisancho-Kiss, 2006, Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4, Brain Research, 1126, 139, 10.1016/j.brainres.2006.08.003 Gately, 1992, Regulation of human cytolytic lymphocyte responses by interleukin-12, Cellular Immunology, 143, 127, 10.1016/0008-8749(92)90011-D Gluck, 2001, Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice, Journal of Molecular and Cellular Cardiology, 33, 1615, 10.1006/jmcc.2001.1416 Han, 2012, Experimental SSM-CVB3 infection in macaques, Experimental and Molecular Pathology, 92, 131, 10.1016/j.yexmp.2011.10.008 Hara, 1983, Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin, Microbiology and Immunology, 27, 1057, 10.1111/j.1348-0421.1983.tb02939.x He, 2009, The evidence of Coxsackievirus B3 induced myocarditis as the cause of death in a Sichuan snub-nosed monkey (Rhinopithecus roxellana), Journal of Medical Primatology, 38, 192, 10.1111/j.1600-0684.2008.00336.x Heremans, 1989, The potential role of interferons and interferon antagonists in inflammatory disease, Drugs, 38, 957, 10.2165/00003495-198938060-00007 Hirano, 1992, Molecular biology and immunology of interleukin-6, Research in Immunology, 143, 723, 10.1016/0923-2494(92)80010-I Hoshino, 1983, Experimental coxsackie B viral myocarditis in cynomolgus monkeys, Japanese Circulation Journal, 47, 59, 10.1253/jcj.47.59 Huber, 2004, Coxsackievirus-induced pancreatitis, Viral Immunology, 17, 358, 10.1089/vim.2004.17.358 Huber, 1998, Enteroviruses and myocarditis: viral pathogenesis through replication, cytokine induction, and immunopathogenicity, Advances in Virus Research, 51, 35, 10.1016/S0065-3527(08)60783-6 Hutchinson, 2001, Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype), Journal of Medical Virology, 65, 561, 10.1002/jmv.2073 Ilback, 1989, Effects of the immunomodulator LS 2616 on lymphocyte subpopulations in murine Coxsackievirus B3 myocarditis, Journal of Immunology, 142, 3225, 10.4049/jimmunol.142.9.3225 Ilback, 1993, Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease, Scandinavian Journal of Infectious Diseases. Supplementum, 88, 117 Jun, 2001, The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals, Diabetologia, 44, 271, 10.1007/s001250051614 Katz, 1994, Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation, Circulation, 90, 12, 10.1161/01.CIR.90.1.12 Kawai, 1999, From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future, Circulation, 99, 1091, 10.1161/01.CIR.99.8.1091 Kelly, 1978, Coxsackievirus in an infant chimpanzee, Journal of Medical Primatology, 7, 119, 10.1159/000459795 Kiniwa, 1992, Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes, The Journal of Clinical Investigation, 90, 262, 10.1172/JCI115846 Levine, 1990, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure, The New England Journal of Medicine, 323, 236, 10.1056/NEJM199007263230405 Lundgren, 1971, Experimental infection of beagle dogs with Coxsackievirus type B1, American Journal of Veterinary Research, 32, 609 Lundgren, 2009, Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice, Toxicology Letters, 184, 107, 10.1016/j.toxlet.2008.10.021 Lundgren, 2009, Sequential changes in serum cytokines reflect viral RNA kinetics in target organs of a coxsackievirus B infection in mice, Journal of Clinical Immunology, 29, 611, 10.1007/s10875-009-9294-8 Mackay, 2001, Chemokines: immunology's high impact factors, Nature Immunology, 2, 95, 10.1038/84298 Maisch, 2002, Pathophysiology of viral myocarditis: the role of humoral immune response, Cardiovascular Pathology, 11, 112, 10.1016/S1054-8807(01)00113-2 Matsumori, 1997, Molecular and immune mechanisms in the pathogenesis of cardiomyopathy—role of viruses, cytokines, and nitric oxide, Japanese Circulation Journal, 61, 275, 10.1253/jcj.61.275 Matsumori, 1994, Increased circulating cytokines in patients with myocarditis and cardiomyopathy, British Heart Journal, 72, 561, 10.1136/hrt.72.6.561 Matsuzaki, 2007, Interleukin-17 as an effector molecule of innate and acquired immunity against infections, Microbiology and Immunology, 51, 1139, 10.1111/j.1348-0421.2007.tb04008.x Miyagi, 1999, Coxsackievirus B4 myocarditis in an orangutan, Veterinary Pathology, 36, 452, 10.1354/vp.36-5-452 Mosmann, 1991, The role of IL-10 in crossregulation of TH1 and TH2 responses, Immunology Today, 12, A49, 10.1016/S0167-5699(05)80015-5 Olsson, 2005, Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans, Biochemical and Biophysical Research Communications, 330, 571, 10.1016/j.bbrc.2005.03.016 Ramsingh, 2008, CVB-induced pancreatitis and alterations in gene expression, Current Topics in Microbiology and Immunology, 323, 241 Salazar-Mather, 2003, Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks, Viral Immunology, 16, 291, 10.1089/088282403322396109 Salazar-Mather, 2006, Cytokine and chemokine networks: pathways to antiviral defense, Current Topics in Microbiology and Immunology, 303, 29 Schmidtke, 2000, Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis, Journal of Medical Virology, 61, 518, 10.1002/1096-9071(200008)61:4<518::AID-JMV16>3.0.CO;2-F Scott, 1993, IL-12: initiation cytokine for cell-mediated immunity, Science, 260, 496, 10.1126/science.8097337 Shen, 2004, Coxsackievirus group B type 3 infection upregulates expression of monocyte chemoattractant protein 1 in cardiac myocytes, which leads to enhanced migration of mononuclear cells in viral myocarditis, Journal of Virology, 78, 12548, 10.1128/JVI.78.22.12548-12556.2004 Shi, 2009, Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo, Journal of the American College of Cardiology, 53, 1219, 10.1016/j.jacc.2008.10.064 Shioi, 1996, Persistent expression of cytokine in the chronic stage of viral myocarditis in mice, Circulation, 94, 2930, 10.1161/01.CIR.94.11.2930 Smith, 1999, Introduction to immunology and autoimmunity, Environmental Health Perspectives, 107, 661, 10.1289/ehp.99107s5661 Stechova, 2007, High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes, Diabetes/Metabolism Research and Reviews, 23, 462, 10.1002/dmrr.718 Tomioka, 1986, Effects of prednisolone on acute viral myocarditis in mice, Journal of the American College of Cardiology, 7, 868, 10.1016/S0735-1097(86)80349-7 Wang, 2009, The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3, Phytomedicine, 16, 146, 10.1016/j.phymed.2008.07.013 Warren, 1990, Interleukins and tumor necrosis factor in inflammation, Critical Reviews in Clinical Laboratory Sciences, 28, 37, 10.3109/10408369009105897 Whitton, 2002, Immunopathology during coxsackievirus infection, Springer Seminars in Immunopathology, 24, 201, 10.1007/s00281-002-0100-4 Wilson, 1969, Residual pathologic changes following murine coxsackie A and B myocarditis, The American Journal of Pathology, 55, 253 Yoon, 1986, Coxsackie virus B4 produces transient diabetes in nonhuman primates, Diabetes, 35, 712, 10.2337/diab.35.6.712